SAN DIEGO--(BUSINESS WIRE)--SynteractHCR, a full-service, international contract research organization (CRO), will be sharing its expertise with members of the biopharmaceutical and life science communities at three separate events this fall: a European CRO Federation (EUCROF) webinar on global pediatric regulations, Outsourcing in Clinical Trials Southern California and Outsourcing in Clinical Trials New England.
Dr. Martine Dehlinger-Kremer, Global Vice President, Medical and Regulatory Affairs at SynteractHCR and chair of the Pediatric Working Group of EUCROF, will deliver the webinar entitled, “Global Pediatric Regulations: Where are we today?” on Sept. 10 from 10:30 a.m. to 12:00 p.m. CET. Its purpose is to educate attendees on legislative requirements in the U.S. and Europe to help solve the global challenges of pediatric drug development. Dr. Dehlinger-Kremer has more than 19 years of experience in international medical and regulatory affairs and is an expert on the subject.
Dr. Dehlinger-Kremer is also a featured speaker at the second industry event, Outsourcing in Clinical Trials Southern California (OCT Southern California). She will present “The New EU Clinical Trials Regulation: the Good, the Bad, and the Ugly” on September 23 at 3:30 p.m. This presentation focuses on the core components of the European Regulation on clinical trials, including its advantages, disadvantages, the impact it will have on sponsors worldwide and a timeline for its implementation. OCT Southern California brings together more than 200 pharmaceutical, biotechnology and medical device professionals to network and learn from other case-study based presentations. OCT Southern California will run from Sept. 23-24 at the San Diego Marriott in La Jolla, Calif.
SynteractHCR will also participate at Outsourcing in Clinical Trials: New England (OCT New England) from October 7-8 in Boston, Mass. This conference is the flagship event of the global OCT series and is host to more than 50 speakers and presenters. On October 8 at 2:45 p.m. SynteractHCR Project Director Cheryl Johnson will present “Achieving a Key Milestone: Site Activation” to educate attendees on identifying critical steps for activating a site, implementing effective tracking and handling proactive management and site communication.
About SynteractHCR (www.synteracthcr.com)
SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. SynteractHCR has conducted Phase I-IV studies on six continents and in more than 50 countries, offering expertise across multiple therapeutic areas, with notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications. With its “Shared Work – Shared Vision” philosophy and ICD+ approach, SynteractHCR provides customized services collaboratively and cost effectively, ensuring on-time delivery of quality data so clients get to decision points faster.